Human G-protein receptor HPRAJ70
    33.
    发明授权
    Human G-protein receptor HPRAJ70 有权
    人类G蛋白受体HPRAJ70

    公开(公告)号:US06372891B1

    公开(公告)日:2002-04-16

    申请号:US09339115

    申请日:1999-06-24

    IPC分类号: C07K1628

    CPC分类号: C07K16/28 A61K2039/505

    摘要: Human G-protein coupled receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed were methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the G-protein coupled receptor polypeptides. Also disclosed are diagnostic methods for detecting a mutation, in the G-protein coupled receptor nucleic acid sequences and an altered level of the soluble form of the receptors.

    摘要翻译: 公开了人G-蛋白偶联受体多肽和编码此类多肽的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这些多肽来鉴定此类多肽的拮抗剂和激动剂的方法,以及在治疗性地使用激动剂和拮抗剂治疗与G蛋白偶联受体多肽的低表达和过度表达相关的病症的方法。 还公开了用于检测G蛋白偶联受体核酸序列中的突变和受体可溶形式的改变水平的诊断方法。

    Polynucleotides encoding human G-protein coupled receptor GPR1
    34.
    发明授权
    Polynucleotides encoding human G-protein coupled receptor GPR1 失效
    编码人G蛋白偶联受体GPR1的多核苷酸

    公开(公告)号:US6090575A

    公开(公告)日:2000-07-18

    申请号:US467947

    申请日:1995-06-06

    CPC分类号: C07K14/705 A61K48/00

    摘要: Human G-protein coupled receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the G-protein coupled receptor polypeptides, respectively. Also disclosed are diagnostic methods for detecting a mutation in the G-protein coupled receptor nucleic acid sequences and an altered level of the soluble form of the receptors.

    摘要翻译: 公开了人G-蛋白偶联受体多肽和编码此类多肽的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这些多肽来鉴定此类多肽的拮抗剂和激动剂的方法,以及分别在治疗上使用激动剂和拮抗剂治疗与G蛋白偶联受体多肽的低表达和过表达相关的病症的方法。 还公开了用于检测G蛋白偶联受体核酸序列中的突变和受体的可溶形式的改变水平的诊断方法。

    Polynucleotides encoding G-protein parathyroid hormone receptor HLTDG74
polypeptides
    35.
    发明授权
    Polynucleotides encoding G-protein parathyroid hormone receptor HLTDG74 polypeptides 失效
    编码G蛋白甲状旁腺激素受体HLTDG74多肽的多核苷酸

    公开(公告)号:US6030804A

    公开(公告)日:2000-02-29

    申请号:US468011

    申请日:1995-06-06

    摘要: Human G-protein parathyroid hormone (PTH) receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the PTH receptor receptor polypeptides. Also disclosed are diagnostic methods for detecting a mutation in the PTH receptor receptor nucleic acid sequences and detecting a level of the soluble form of the receptors in a sample derived from a host.

    摘要翻译: 公开了人类G蛋白甲状旁腺激素(PTH)受体多肽和编码此类多肽的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这些多肽来鉴定此类多肽的拮抗剂和激动剂的方法,以及在治疗上使用激动剂和拮抗剂治疗与PTH受体受体多肽的低表达和过表达相关的病症的方法。 还公开了用于检测PTH受体受体核酸序列中的突变并检测衍生自宿主的样品中受体的可溶形式水平的诊断方法。

    Albumin fusion proteins
    39.
    发明授权
    Albumin fusion proteins 有权
    白蛋白融合蛋白

    公开(公告)号:US08143026B2

    公开(公告)日:2012-03-27

    申请号:US12534585

    申请日:2009-08-03

    摘要: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.

    摘要翻译: 本发明包括白蛋白融合蛋白。 编码本发明的白蛋白融合蛋白的核酸分子也包括在本发明中,载体含有这些核酸,用这些核酸载体转化的宿主细胞,以及制备本发明的白蛋白融合蛋白并使用这些核酸的方法 酸,载体和/或宿主细胞。 另外,本发明包括包含白蛋白融合蛋白的药物组合物以及使用本发明的白蛋白融合蛋白来治疗,预防或改善疾病,病症或病症的方法。

    Antibodies to HT5GJ57
    40.
    发明授权
    Antibodies to HT5GJ57 失效
    抗体HT5GJ57

    公开(公告)号:US07932361B2

    公开(公告)日:2011-04-26

    申请号:US12268263

    申请日:2008-11-10

    IPC分类号: C07K16/00

    摘要: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.

    摘要翻译: 本发明涉及含有编码这些蛋白质的基因的编码区的新的人分泌蛋白和分离的核酸。 还提供了用于产生人分泌蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人分泌蛋白相关的疾病,病症和/或病症的诊断和治疗方法。